Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount-Reference-Cited by-同舟云学术

Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount

Published:1999-06-23 Issue:7 Volume:26 Page:693-698
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:
Short-container-title:European Journal of Nuclear Medicine and Molecular Imaging

Author:

de Jong Marion,Breeman Wout A. P.,Bernard Bert F.,van Gameren Arthur,de Bruin Elisa,Bakker Willem H.,van der Pluijm Marcel E.,Visser Theo J.,Mäcke Helmut R.,Krenning Eric P.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s002590050439.pdf

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors;EJNMMI Radiopharmacy and Chemistry;2024-05-22

2. Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review;Pharmaceuticals;2024-03-04

3. Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of 68Ga-, 205/206Bi-, and 177Lu-Labeled NAPamide-Based Radiopharmaceuticals;Pharmaceuticals;2023-09-11

4. Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough;EJNMMI Research;2022-12-14

5. Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer;Scientific Reports;2021-11-19